Botox Injections for Overactive Bladder

N/A

Waitlist Available

Led By Lisa Peacock, MD

Research Sponsored by Louisiana State University Health Sciences Center in New Orleans

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Pursuing treatment with intravesical botulinum toxin injections

Be older than 18 years old

Must not have

Non-OAB diagnosis such as pelvic pain or interstitial cystitis

Timeline

Screening 3 weeks

Treatment Varies

Follow Up days from initial injection to repeat injection, up to 365 days

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to determine if allowing patients to decide their own follow-up times after receiving Botox injections for overactive bladder can improve treatment effectiveness. They want to find out if the time between injections

Who is the study for?

This trial is for individuals with overactive bladder and related urinary issues who have previously responded to botulinum toxin injections. Participants will decide when they need follow-up treatments rather than following a standard schedule.

What is being tested?

The study tests if patient-directed follow-up times for botulinum toxin injections into the bladder are more effective than the usual 6-month interval in managing symptoms of overactive bladder.

What are the potential side effects?

Botulinum toxin may cause side effects like urinary tract infections, difficulty urinating, or discomfort at the injection site. Some people might also experience general weakness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am considering or planning to receive Botox injections in my bladder.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I have been diagnosed with conditions like pelvic pain or interstitial cystitis, not OAB.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ days from initial injection to repeat injection, up to 365 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~days from initial injection to repeat injection, up to 365 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and days from initial injection to repeat injection, up to 365 days for reporting.